GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Institutional Ownership

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Institutional Ownership : 0.04% (As of Jun. 06, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Parnell Pharmaceuticals Holdings's institutional ownership is 0.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Parnell Pharmaceuticals Holdings's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Parnell Pharmaceuticals Holdings's Float Percentage Of Total Shares Outstanding is 59.82%.


Parnell Pharmaceuticals Holdings Institutional Ownership Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Institutional Ownership Chart

Parnell Pharmaceuticals Holdings Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings can be seen below:

2017-07-31 2017-08-31 2017-09-30 2017-10-31 2017-11-30 2018-01-31 2018-02-28 2018-03-31 2018-04-30 2018-05-31
Institutional Ownership 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.04 0.04

Parnell Pharmaceuticals Holdings Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Traded in Other Exchanges
N/A
Address
476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015
Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.